University Of Louisville
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 1798-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.louisville.edu
Risk Factors for Progressive Supranuclear Palsy (PSP)
Completed
- Conditions
- First Posted Date
- 2007-02-05
- Last Posted Date
- 2017-04-10
- Lead Sponsor
- University of Louisville
- Target Recruit Count
- 942
- Registration Number
- NCT00431301
- Locations
- ๐บ๐ธ
University of Colorado, Aurora, Colorado, United States
๐บ๐ธEmory College of Medicine, Atlanta, Georgia, United States
๐บ๐ธRush University, Chicago, Illinois, United States
Racial Disparity in Endometrial Cancer
Terminated
- Conditions
- First Posted Date
- 2006-09-13
- Last Posted Date
- 2018-01-09
- Lead Sponsor
- University of Louisville
- Target Recruit Count
- 43
- Registration Number
- NCT00375804
- Locations
- ๐บ๐ธ
James Graham Brown Cancer Center, Louisville, Kentucky, United States
Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)
Phase 2
Terminated
- Conditions
- First Posted Date
- 2006-02-13
- Last Posted Date
- 2018-05-04
- Lead Sponsor
- University of Louisville
- Target Recruit Count
- 2
- Registration Number
- NCT00290407
- Locations
- ๐บ๐ธ
James Graham Brown Cancer Center, Louisville, Kentucky, United States
Prognostic Markers of Gynecologic Cancers
Completed
- Conditions
- First Posted Date
- 2006-02-13
- Last Posted Date
- 2021-03-30
- Lead Sponsor
- University of Louisville
- Target Recruit Count
- 1321
- Registration Number
- NCT00290459
- Locations
- ๐บ๐ธ
James Graham Brown Cancer Center, Louisville, Kentucky, United States
Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer
- First Posted Date
- 2006-01-24
- Last Posted Date
- 2018-03-29
- Lead Sponsor
- University of Louisville
- Target Recruit Count
- 26
- Registration Number
- NCT00281021
Oxaliplatin in Combination With Capecitabine and Concurrent Radiation Therapy in Non-Small Cell Lung Cancer
Phase 1
Terminated
- Conditions
- First Posted Date
- 2005-12-22
- Last Posted Date
- 2018-03-05
- Lead Sponsor
- University of Louisville
- Target Recruit Count
- 24
- Registration Number
- NCT00268151
- Locations
- ๐บ๐ธ
James Graham Brown Cancer Center, Louisville, Kentucky, United States
Ovarian Screening Study
Completed
- Conditions
- First Posted Date
- 2005-12-20
- Last Posted Date
- 2018-01-09
- Lead Sponsor
- University of Louisville
- Target Recruit Count
- 5000
- Registration Number
- NCT00267072
- Locations
- ๐บ๐ธ
James Graham Brown Cancer Center, Louisville, Kentucky, United States
Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies
- First Posted Date
- 2005-12-16
- Last Posted Date
- 2020-09-03
- Lead Sponsor
- University of Louisville
- Target Recruit Count
- 17
- Registration Number
- NCT00266279
- Locations
- ๐บ๐ธ
University of Louisville, James Graham Brown Cancer Center, Louisville, Kentucky, United States
Human Papilloma Virus DNA Self-Test
Completed
- Conditions
- First Posted Date
- 2005-12-16
- Last Posted Date
- 2017-12-29
- Lead Sponsor
- University of Louisville
- Target Recruit Count
- 171
- Registration Number
- NCT00266266
- Locations
- ๐บ๐ธ
James Graham Brown Cancer Center, Louisville, Kentucky, United States
Using TRAP to Evaluate the Effect of Zometa on Bone Metastasis Due to Lung Cancer
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2005-12-14
- Last Posted Date
- 2018-03-05
- Lead Sponsor
- University of Louisville
- Target Recruit Count
- 28
- Registration Number
- NCT00265200
- Locations
- ๐บ๐ธ
James Graham Brown Cancer Center, Louisville, Kentucky, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath